Overview – Imaging studies & analysis

ADMdx provides imaging study design, management, and centralized analysis for the evaluation of pharmaceutical compounds from preclinical stages through all clinical phases.  Our expertise in PET imaging of CNS compounds, our strengths in DTI, fMRI, and other MR based modalities, and our customer focus set us apart as a provider of excellence.


  • Study design
  • Protocol development
  • Site selection and qualification
  • Imaging charter development
  • Acquisition manual development
  • Study start-up
  • Site management
  • Data management
  • Data quality control (QC)
  • Image processing and analysis
  • Comparisons to reference data
  • Study closeout
  • Reporting
  • Data archiving

Therapeutic Areas (CNS Disorders):

  • Alzheimer’s Disease and precursor stages
  • Frontotemporal Dementia, other dementias
  • Parkinson’s Disease, Parkinsonian disorders
  • Pain
  • Brain tumors
  • Neuropsychiatric disorders
  • Anxiety
  • Schizophrenia
  • Depression
  • ADHD
  • Addiction
  • Sleep disorders